Dr. Dean Li, a Merck executive, said on Thursday that preliminary laboratory studies suggested that the drug was equally effective against Omicron as it was against earlier versions of the virus. The company and independent researchers have been running experiments on how well the drug can stop the Omicron variant from replicating.The pills from Merck…
